Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...

Flatiron Health, a healthtech company transforming clinical research through technology that integrates research into everyday care, today announced a collaboration with NRG Oncology (NRG), a clinical ...

The START Center for Cancer Research ("START"), a global leader in early-phase oncology clinical trials, announces the expansion of its network with the acquisition of Carolina Urologic Research ...

After Trump signed an executive order cutting NIH funds to universities, this Rushville-born professor is seeing the negative effects ...

A recent study on cell-cultivated fish has produced promising results that could put seafood back on the menu for the three ...

Investing.com -- Shares of Incyte Corporation (NASDAQ: INCY) fell 14% after the biopharmaceutical company announced topline results from two Phase 3 clinical trials of povorcitinib in patients with ...

IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sc ...

A leaked memo for grant management staff of the US government's National Institutes of Health, dated 25 March, instructs ...

A Dundee academic has been awarded a prestigious national prize for his work on neurodegenerative diseases, including ...

About STOP-HS The STOP-HS clinical trial program includes two Phase 3 studies ... including statements regarding the regulatory submissions for povorcitinib worldwide; the submission of STOP-HS data ...